Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study.

What Was Tested

Researchers studied Human Growth Hormone in this randomized controlled trial publication.

Who Took Part

The study group was 32 adults.

PubMed indexes the participants as adults and middle-aged adults, both men and women.

Large artery stiffness was assessed by pulse wave analysis of the radial artery pressure waveform, allowing determination of the corresponding central arterial pressure waveform and derivation of the augmentation index.

How the Study Was Run

In design terms this was a randomized, double-blind and placebo-controlled study.

Random assignment meant chance, not the researchers, decided who got Human Growth Hormone and who got the comparison, which limits bias.

Neither the adults nor the staff measuring them knew who was on Human Growth Hormone, so expectations could not easily colour the readings.

A placebo (an inactive look-alike) gave the Human Growth Hormone group a baseline to be compared against.

Endothelial function was assessed using ultrasonic wall tracking to measure flow-mediated dilatation (FMD) of the brachial artery.

Fasting lipid profiles, glucose and insulin were also measured.

What Was Measured

PubMed files the paper under topics including Brachial Artery, Endothelium, Vascular, Human Growth Hormone, Hypopituitarism, Muscle, Smooth, Vascular, Pulsatile Flow and Radial Artery.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Human Growth Hormone in 32 adults.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

Its findings take up roughly 11 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2002 (Clinical endocrinology), a journal based in England.

More context: the related Exogenous HGH, sermorelin & older GHRPs (why they're passed over) library page, all human trials.